Horizon Kinetics Medical ETF MEDX

Morningstar Medalist Rating

Morningstar’s Analysis MEDX

Will MEDX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Horizon Kinetics Medical ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MEDX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings71.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

21.474M
Healthcare

AbbVie Inc

10.102M
Healthcare

US BANK MMDA - USBGFS 7

7.801M
Cash and Equivalents

Novartis AG ADR

6.861M
Healthcare

Johnson & Johnson

6.061M
Healthcare

Amgen Inc

4.87861,764
Healthcare

Alkermes PLC

4.79846,753
Healthcare

AstraZeneca PLC

4.71834,163
Healthcare

Merck & Co Inc

4.33766,794
Healthcare

Bristol-Myers Squibb Co

4.25751,132
Healthcare

Sponsor Center